当前位置:科学网首页 > 小柯机器人 >详情
研究揭示COVID-19患者CD8+T细胞可识别的SARS-CoV-2共享表位
作者:小柯机器人 发布时间:2020/10/22 15:15:33

美国TScan疗法公司Gavin MacBeath研究组发现,COVID-19患者的CD8+T细胞可识别SARS-CoV-2中的共享表位,其中大多数不位于突刺蛋白中。这一研究成果于2020年10月20日在线发表在国际学术期刊《免疫》上。

研究人员使用了无偏全基因组筛选技术来确定SARS-CoV-2中精确的肽序列,该序列可被COVID-19患者的记忆CD8+T细胞识别。总体而言,研究人员为六种最普遍的人类白细胞抗原(HLA)类型中的每种识别了3–8个表位。这些表位在患者之间广泛共享,并且位于病毒中不受突变变异影响的区域。
 
值得注意的是,在29个共有表位中只有3个位于刺突蛋白中,而大多数表位位于ORF1ab或核衣壳蛋白中。研究人员还发现,CD8+T细胞通常不会与引起普通感冒的四种季节性冠状病毒中的表位发生交叉反应。
 
总体而言,这些发现可以为下一代疫苗的开发提供信息,从而可以更好地概括天然CD8+T细胞对SARS-CoV-2的免疫力。
 
据悉,开发预防或治疗COVID-19的有效策略需要了解对SARS-CoV-2的天然免疫反应。
 
附:英文原文

Title: Unbiased screens show CD8+ T cells of COVID-19 patients recognize shared epitopes in SARS-CoV-2, most of which are not located in the Spike protein

Author: Andrew P. Ferretti, Tomasz Kula, Yifan Wang, Dalena M.V. Nguyen, Adam Weinheimer, Garrett S. Dunlap, Qikai Xu, Nancy Nabilsi, Candace R. Perullo, Alexander W. Cristofaro, Holly J. Whitton, Amy Virbasius, Kenneth J. Olivier, Lyndsey R. Buckner, Angela T. Alistar, Eric D. Whitman, Sarah A. Bertino, Shrikanta Chattopadhyay, Gavin MacBeath

Issue&Volume: 2020-10-20

Abstract: Developing effective strategies to prevent or treat COVID-19 requires understanding the natural immune response to SARS-CoV-2. We used an unbiased, genome-wide screening technology to determine the precise peptide sequences in SARS-CoV-2 that are recognized by the memory CD8+ T cells of COVID-19 patients. In total, we identified 3–8 epitopes for each of the six most prevalent human leukocyte antigen (HLA) types. These epitopes were broadly shared across patients and located in regions of the virus that are not subject to mutational variation. Notably, only 3 of the 29 shared epitopes were located in the spike protein, whereas most epitopes were located in ORF1ab or the nucleocapsid protein. We also found that CD8+ T cells generally do not cross-react with epitopes in the four seasonal coronaviruses that cause the common cold. Overall, these findings can inform development of next-generation vaccines that better recapitulate natural CD8+ T cell immunity to SARS-CoV-2.

DOI: 10.1016/j.immuni.2020.10.006

Source: https://www.cell.com/immunity/fulltext/S1074-7613(20)30447-7

期刊信息

Immunity:《免疫》,创刊于1994年。隶属于细胞出版社,最新if:21.522
官方网址:https://www.cell.com/immunity/home
投稿链接:https://www.editorialmanager.com/immunity/default.aspx